Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
38 Cards in this Set
- Front
- Back
Drug
|
Chemical capable of producing a biological effect
|
|
Pharmacology
|
The study of mechanisms of drug action
|
|
Pharmacokinetics
|
What does the body do with the drug?
Absorption Distribution Metabolism Excretion |
|
Pharmacodynamics
|
What does the drug do to the body?
|
|
Toxicology
|
The study of poisons and harmful effects of drugs
|
|
Therapeutics
|
Treating disease with drugs
|
|
Pharmacy
|
Preparation, dispensing, and use of drugs
|
|
Pharmacognosy
|
Drug extraction from natural products
|
|
Pharmaceutics
|
Formulation of drugs
|
|
Drug Sources
|
Plants (Alkaloids)
Animals (Hormones) Minterals Synthetics |
|
Tablets/Capsules
|
Active constituents with inert ingredients
|
|
Enteric Coatings
|
Polymers that will not disintegrate in gastric acid but will break down in the more alkaline intestines
|
|
Syrup
|
Sweetened aqueous solution
|
|
Elixir
|
Sweetened aqueous-alcoholic solutions
|
|
Enteral Administration
|
Oral, Rectal, Buccal, Sublingual
|
|
Parenteral Administration
|
Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intrathecal, Intra-articular
|
|
Intrathecal Administration
|
Injection of a drug through the theca of the spinal cord into the subarachnoid space
|
|
Intra-articular Administration
|
Injection of a drug into a joint
|
|
Chemical Name
|
Specifies the chemical structure of the drug w/standard chemical nomenclature
|
|
Nonproprietary/Generic Name
|
Determined by the United States Adopted Names Council (USAN). Most appropriate for use in clinical practice.
|
|
Proprietary/Trade/Brand Name
|
Registered trademark belonging to a particular drug manufacturer and used to designate a drug product marketed by the manufacturer.
|
|
Primary Routes of Administration
|
Enteral, Parenteral, Transdermal, Inhalational, Topical
|
|
Routes That Avoid First Pass Hepatic Metabolism
|
Transdermal, Sublingual, Parenteral
|
|
Weak Acid
|
Chemical that is NOT charged when it is protonated
Only absorbed when protonated |
|
Weak Base
|
Chemical that IS charged when it is protonated
Only absorbed when NOT protonated |
|
pKa
|
the pH at which equal amounts of drug are charged and uncharged
|
|
Volume of Distribution (Vd)
|
The volume of fluid in which a drug would need to be dissolved to have the same concentration in that volume as it does in the plasma
|
|
Cp0
|
Concentration in plasma at time zero
|
|
Phase I Biotransformation
|
Oxidation, hydrolysis, or reduction
|
|
Phase II Biotransformation
|
Conjugation
|
|
Prodrugs
|
Administered as inactive compounds, but become active metabolites after biotransformation
|
|
Drug Biotransformation
|
Enzymatic metabolism of drugs to terminate the effect of a xenobiotic, or to activate a prodrug
|
|
Phase I Biotransformation
|
Oxidation, Hydrolysis, Reduction
|
|
Phase II Biotransformation
|
Conjugation
|
|
Influences of Drug Biotransformation
|
Genetics, Age, Pathology, Other Drugs
|
|
3 Phases of Renal Excretion
|
Glomerular Filtration, Active Tubular Secretion, Tubular Re-Absorption
|
|
Routes of Excretion
|
Renal (most), Biliary (high molecular weights), sweat, saliva
|
|
First Order Elimination Kinetics
|
Fraction of drug is removed per unit time.
Dependent upon plasma drug concentration. |